Skip to main content
MedPathMedPath Home
Clinical Trials/NCT00165750
NCT00165750
Terminated
Phase 4

Correlation Between Regional Brain Volume and Response to Donepezil Treatment in AD Patients

Eisai Korea Inc.1 site in 1 country40 target enrollmentMarch 2005
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsAlzheimer's Disease
InterventionsDONEPEZIL HYDROCHLORIDE
DrugsDONEPEZIL HYDROCHLORIDE

Overview

Phase
Phase 4
Intervention
DONEPEZIL HYDROCHLORIDE
Conditions
Alzheimer's Disease
Sponsor
Eisai Korea Inc.
Enrollment
40
Locations
1
Primary Endpoint
MRI, ADAS-cog
Status
Terminated
Last Updated
12 years ago
OverviewInvestigatorsEligibility CriteriaArms & InterventionsOutcomesSitesSimilar Trials

Overview

Brief Summary

This study investigate the relationship between regional brain volume measured by MRI and donepezil treatment response in patients with Alzheimer's Disease.

Registry
clinicaltrials.gov
Start Date
March 2005
End Date
November 2008
Last Updated
12 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Arms & Interventions

1

Intervention: DONEPEZIL HYDROCHLORIDE

Outcomes

Primary Outcomes

MRI, ADAS-cog

Time Frame: 0, 12, 24 weeks

Secondary Outcomes

  • ADL, BPSD, CDR-SB, ZBI, GHQ, CIBIC plus(0, 12, 24 weeks)

Study Sites (1)

Loading locations...

Similar Trials

Withdrawn
Not Applicable
Correlation of Volumetric Brain Analysis With Development at 18 MonthsChild Development
NCT00194831Weill Medical College of Cornell University
Unknown
Not Applicable
Brain Hippocampal Volume Relationship With Anxious Symptoms in Major Depressive PatientsMajor Depressive DisorderAnxiety Disorders
NCT04430556Hospital Universitario Dr. Jose E. Gonzalez30
Completed
Not Applicable
The change in regional cerebral blood volume and oxygenation during robot-assisted laparoscopic radical prostatectomyProstate cancer
JPRN-UMIN000025465ihon University School of Medicine20
Completed
Phase 3
Positron Emission Tomography (PET) Imaging of Brain Amyloid Compared to Post-Mortem LevelsBrain Fibrillarab Levels
NCT01165554GE Healthcare203
Active, not recruiting
Not Applicable
DSC-MRI in Measuring rCBV for Early Response to Bevacizumab in Patients With Recurrent GlioblastomaGliosarcomaRecurrent Glioblastoma
NCT03115333ECOG-ACRIN Cancer Research Group146